Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Washington Penn is an active U.S.-based manufacturer specializing in custom polypropylene and polyethylene compound solutions primarily serving industrial sectors such as automotive, appliances, construction materials—with additional product lines tailored for medical devices requiring features like antimicrobial surfaces. The company was founded in 1954 by Albert Andy and his brothers. It operates globally under the parentage of the Audia Group but does not engage directly in drug development or core life sciences activities. While some products are used within healthcare settings—such as hospital beds or device housings—the business itself is best classified within advanced materials manufacturing rather than biotech/pharma/healthcare proper.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Washington Penn.